Study: PrEP demonstrates effectiveness, but alongside growing STI rate FDA approves Brilinta 60 mg tablets Novartis, Amgen team on migraine, Alzheimer’s drug development Sandoz introduces rivastigmine patch Kaleo launches campaign on safe opioid use PrescribeWellness intros PrescribeMedicare Teva launches Zecuity migraine patch Allergan completes Naurex acquisition FDA unveils draft guidance for naming biosimilars FDA approves Synjardy tablets First Previous 121 122 123 124 125 Next Last